Avantax Advisory Services’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$949K Sell
7,626
-4,641
-38% -$599K 0.01% 1200
2025
Q1
$577K Sell
12,267
-1,750
-12% -$85.4K ﹤0.01% 1415
2024
Q4
$444K Sell
14,017
-2,000
-12% -$57K ﹤0.01% 1525
2024
Q3
$348K Buy
+16,017
New +$231K ﹤0.01% 1654
2024
Q2
Sell
-196
Closed -$2.82K 2113
2024
Q1
$2.82K Hold
196
﹤0.01% 1647
2023
Q4
$5.29K Hold
196
﹤0.01% 1569
2023
Q3
$5.95K Hold
196
﹤0.01% 1543
2023
Q2
$12.4K Hold
196
﹤0.01% 1497
2023
Q1
$29.7K Sell
196
-240
-55% -$48.6K ﹤0.01% 1460
2022
Q4
$124K Buy
+436
New +$83.7K ﹤0.01% 1354

Other funds holding NUTX

Avantax Advisory Services's NUTX Position: Q2 2025 in Review

Avantax Advisory Services reduced its Nutex Health (NUTX) stake by 38% in Q2 2025, selling an estimated $599K and leaving 7,626 shares worth $949K. The position accounts for 0.01% of the portfolio, ranked #1200.

Avantax Advisory Services first reported a position in NUTX in Q4 2022 and has held it in 10 quarters since. 102 funds tracked by Wall St. Rank hold NUTX as of Q2 2025.

  • Avantax Advisory Services held 7,626 shares of Nutex Health worth $949K as of Q2 2025.
  • Avantax Advisory Services sold 4,641 Nutex Health shares in Q2 2025, an estimated $599K.
  • Nutex Health made up 0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1200 holding.
  • Avantax Advisory Services first reported a position in Nutex Health in Q4 2022 and has held it in 10 quarters since.
  • 102 funds tracked by Wall St. Rank held Nutex Health as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.